

UE LifeSciences - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2009, UE LifeSciences operates in the health technology sector, focusing on innovative solutions for early cancer detection. The company initially centered on the development of non-invasiv...
Funding stage:
Seed
Last funding:
22/11/2021
Total funding:
$4.78 Mn+
Revenue:
Investors
Employee count:
64
Last 90d
64
Last 90d
Web traffic:
2.01K
2.01K
Last 30d
Last 30d
Glassdoor Rating:
UE LifeSciences: Funding Highlights
Funding highlights of UE LifeSciences and a snapshot of its key metrics.
- Total Funding$4.78 Mn+
- Current StageEarly Stage
- Total Round(s)4
Funding Rounds
FAQs on Funding of UE LifeSciences
Health Tech Funded UE LifeSciences has raised a total funding of $4.78 million as of 23 November 2021 across 4 rounds. Find the details around funding rounds, participating investors, and other insights of UE LifeSciences here...
UE LifeSciences has raised a total of $4.78 million across 4 funding rounds and the last round was raised on 23 November 2021.
UE LifeSciences's key investors include Unitus Ventures, Aarin Capital, Kiran Mazumdar-Shaw and 1 other.
UE LifeSciences's latest funding round was $480.31K in Early Stage, raised on 23 November 2021.
UE LifeSciences is at the Early stage. Its most recent round was raised on 23 November 2021.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links